HCL recognized as a Leader in Avasant’s Hybrid Enterprise Cloud Services RadarView™ Report 2019 – 2020

Among endless service provider options, novel and disruptive mechanics in innovation brings recognition as a Leader for Hybrid Enterprise Cloud Services 2019-2020.

Read the Avasant report

Steadily maturing cloud practice backed by robust IPs and diverse partner network. Laser-focused on IP development and significant IBM deal.

luxoft - New Radar view


Learn More


Practice Maturity

  • HCL offers hybrid cloud services under their Mode-2 strategy, providing a set of services that spans advisory, migration, implementation, governance, security, and orchestration. In 2019, its hybrid cloud practice grew between 20-30% and has won 60 new clients.
  • It has taken an IP-centric approach and made strategic investments in developing reusable assets: MyCloud (cloud management), ATMA (cloud migration), and iAssure (cloud operations & maintenance). Its cloud-ready toolset is integrated with DRYiCE suite of automation-related products, including ElasticOps, iAutomate, LUCY, MyXalytics among others.
  • In addition to homegrown IPs, it has also created multiple horizontal and vertical solutions as part of client engagements, including financial services (lending and mortgage default management), supply chain (Track and Trace) and healthcare (Patient Support as-a-service).
  • It has a well-distributed customer base across multiple geographies. In the past 12 months, Energy & Utilities (+7% YoY) and Healthcare & Life Sciences (+5% YoY) saw significant traction and new logos. HCL is helping 2 leading gas distribution companies in the UK with hybrid cloud managed services.
Leader IA Badge 4 - New Radar view

Partnership Ecosystem

  • HCL works closely with nearly all major cloud and technology providers and has developed a certified workforce for its cloud platforms. It has a strategic alliance with Microsoft where it has invested in Lab 21, focused on developing Cortana’s competencies, and GTM for Azure cloud solutions.
  • As part of its recent IBM deal, HCL will leverage seven (7) IBM products including Lotus Notes, R&D, sales, marketing, delivery, and provide support for AppScan, BigFix, etc. It has also formed a new division called ‘HCL Software’ to help enterprise software product business and meet customer demands.
  • With Pivotal, it has invested USD 10M+ for designing innovation labs and experience centers in London and India. It also offers joint cloud solutions and has trained 100+ resources for mass enablement of Pivotal services.

Investments & Innovation

  • HCL has pioneered a unique inorganic growth model to enhance its cloud-native capabilities. Consequently, it has completed a series of acquisitions, including IBM products (2019), Strong Bridge (2019), Actian (2018), and H&D International Group (2018) among others.
  • It has established 3 exclusive cloud-native innovation labs across London, Dallas, and Noida to co-create and deliver cloud-native solutions to enterprise clients. Recently, it launched HCL-Google’s Cloud Business Unit and intends to ramp up the practice to more than 5,000 specialist from 1,300.
  • It leverages university partnership ecosystem, including Carnegie Mellon, Berkeley, MIT and Stanford University, to cross-skill cloud resources across AI/ML, natural language processing (NLP) and other niche digital technologies.


This graphic was published by Avasant LLC as part of a larger research document and should be evaluated in the context of the entire document. The document is available upon request from Avasant website. Avasant does not endorse any provider, product or service depicted in its research publications, including RadarViewTM, and does not advise users to select only those providers recognized in these publications. Avasant’s research publications are based on information from best available sources and Avasant’s opinion at the time of publication, and their contents should not be construed as statements of fact. Avasant disclaims all warranties, expressed or implied, with respect to this research, including and warranties of merchantability or fitness for a particular purpose.